- 1 April 2021
Australian Prescriber
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals.
-
Volume 44 Issue 2
- April 2021
Editorial
Gregory J Dore
Article
Opioids and antidepressants: which combinations to avoid
Varan Perananthan, Nicholas A. Buckley
- 1 April 2021
Editorial
Naloxone for opioid toxicity and overdose in the community
Marianne E Jauncey, Suzanne Nielsen
- 1 April 2021
-
Article
Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
Article
Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
Richard I. Lindley
- 1 April 2021
-
Letters to the Editor
Caution with olanzapine use in dementia
Letters to the Editor
Caution with olanzapine use in dementia
Mark Coles, Stephen Macfarlane
- 1 April 2021
New drugs
BNT162b2 vaccine for prevention of COVID-19
- 1 April 2021
ChAdOx1-S vaccine for prevention of COVID-19
- 1 April 2021
Cinnarizine/dimenhydrinate for vertigo
- 1 April 2021
Defibrotide for hepatic veno-occlusive disease
- 1 April 2021
Ozanimod for multiple sclerosis
- 1 April 2021
Selexipag for pulmonary arterial hypertension
- 1 April 2021
Siponimod for multiple sclerosis
- 1 April 2021
Early release
SUBSCRIBE TO AUSTRALIAN PRESCRIBER
Subscribe to receive email updates when new Australian Prescriber articles are published
